Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chad E Mire

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Nature Communications|September 12, 2023
A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infectionAdam J Ronk, Nicole M Lloyd, Min Zhang, et al.
Nature Medicine|September 5, 2017
Human-monoclonal-antibody therapy protects nonhuman primates against advanced Lassa feverChad E Mire, Robert W Cross, Joan B Geisbert, et al.
The Journal of Clinical Investigation|December 11, 2019
Quadrivalent VesiculoVax vaccine protects nonhuman primates from viral-induced hemorrhagic fever and deathRobert W Cross, Rong Xu, Demetrius Matassov, et al.
Science Translational Medicine|July 15, 2021
Ebola vaccine-induced protection in nonhuman primates correlates with antibody specificity and Fc-mediated effectsMichelle Meyer, Bronwyn M Gunn, Delphine C Malherbe, et al.
The Journal of Clinical Investigation|August 27, 2021
Attenuated activation of pulmonary immune cells in mRNA-1273-vaccinated hamsters after SARS-CoV-2 infectionMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2021
mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challengeMichelle Meyer, Yuan Wang, Darin Edwards, et al.
Immunity|February 6, 2020
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus NeutralizationPavlo Gilchuk, Charles D Murin, Jacob C Milligan, et al.
Cell Host & Microbe|January 11, 2019
A Two-Antibody Pan-Ebolavirus Cocktail Confers Broad Therapeutic Protection in Ferrets and Nonhuman PrimatesZachary A Bornholdt, Andrew S Herbert, Chad E Mire, et al.
Biorxiv : the Preprint Server for Biology|February 16, 2022
The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamstersLisa Miorin, Chad E Mire, Shahin Ranjbar, et al.
Nature Communications|October 21, 2021
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical modelsPauline Maisonnasse, Yoann Aldon, Aurélien Marc, et al.
Pageof 10